Back to Search
MICHAEL KIES, PHARMD
PHARMD
Pharmacist
NPI: 1699059295Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
051.295270(IL)
Research & Publications (20)
Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
PMID 19362781·Int J Radiat Oncol Biol Phys·2009
6-review
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.
PMID 19289628·J Clin Oncol·2009
8-other
IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
PMID 18556144·Int J Radiat Oncol Biol Phys·2009
8-other
AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance.
PMID 19667402·Blood·2009
4-observational
A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck.
PMID 19433965·Am J Clin Oncol·2009
3-trial
Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.
PMID 18556142·Int J Radiat Oncol Biol Phys·2009
3-trial
Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer.
PMID 19107949·Head Neck·2009
3-trial
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.
PMID 17960324·Invest New Drugs·2008
3-trial
Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".
PMID 19059972·Chest·2008
8-other
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
PMID 18541897·J Clin Oncol·2008
3-trial
Docetaxel in the treatment of squamous cell carcinoma of the head and neck.
PMID 19209269·Ther Clin Risk Manag·2008
8-other
Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer.
PMID 18455324·Int J Radiat Oncol Biol Phys·2008
8-other
NCCN Task Force Report: mTOR inhibition in solid tumors.
PMID 18926092·J Natl Compr Canc Netw·2008
6-review
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis.
PMID 18501527·Int J Radiat Oncol Biol Phys·2008
8-other
Videos in clinical medicine. Examination of the larynx and pharynx.
PMID 18199857·N Engl J Med·2008
8-other
Evaluation and management of the unknown primary carcinoma of the head and neck.
PMID 19176202·J Natl Compr Canc Netw·2008
6-review
Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
PMID 18451230·Clin Cancer Res·2008
4-observational
Induction chemotherapy for head and neck squamous cell carcinomas (SCCHN).
PMID 17952388·Curr Treat Options Oncol·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 N MAIN ST
EAST PEORIA, IL 61611 - Phone
- (309) 694-7661
Quick Facts
- NPI
- 1699059295
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile